Regulatory T cells: A potential weapon to combat COVID‐19?
暂无分享,去创建一个
S. Zheng | B. Ryffel | J. Bellanti | R. Moser | Yu Liu | Guangying Qi
[1] Haibo Xu,et al. Pulmonary Pathology of Early-Phase 2019 Novel Coronavirus (COVID-19) Pneumonia in Two Patients With Lung Cancer , 2020, Journal of Thoracic Oncology.
[2] Jiyuan Zhang,et al. Pathological findings of COVID-19 associated with acute respiratory distress syndrome , 2020, The Lancet Respiratory Medicine.
[3] Guangdi Li,et al. Therapeutic options for the 2019 novel coronavirus (2019-nCoV) , 2020, Nature Reviews Drug Discovery.
[4] W. Liu,et al. Learning from the Past: Possible Urgent Prevention and Treatment Options for Severe Acute Respiratory Infections Caused by 2019‐nCoV , 2020, Chembiochem : a European journal of chemical biology.
[5] Min Chen,et al. The mental health of medical workers in Wuhan, China dealing with the 2019 novel coronavirus , 2020, The Lancet Psychiatry.
[6] Wei Wang,et al. Diagnosis and treatment recommendations for pediatric respiratory infection caused by the 2019 novel coronavirus , 2020, World Journal of Pediatrics.
[7] Z. Fayad,et al. CT Imaging Features of 2019 Novel Coronavirus (2019-nCoV) , 2020, Radiology.
[8] Hong-Mei Song. Keeping up with the progress in the diagnosis and management of pediatric rheumatic diseases , 2020, World Journal of Pediatrics.
[9] Ting Yu,et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study , 2020, The Lancet.
[10] Lisa E. Gralinski,et al. Return of the Coronavirus: 2019-nCoV , 2020, Viruses.
[11] Y. Hu,et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China , 2020, The Lancet.
[12] T. Welte,et al. Increased frequency of CD4+CD25highCD127low T cells early after lung transplant is associated with improved graft survival – a retrospective study , 2020, Transplant international : official journal of the European Society for Organ Transplantation.
[13] S. Zheng,et al. Negligible Effect of Sodium Chloride on the Development and Function of TGF-β-Induced CD4+ Foxp3+ Regulatory T Cells , 2019, Cell reports.
[14] S. Ebrahimpour,et al. CD4+CD25+CD127low FoxP3+ regulatory T cells in Crohn’s disease , 2018, Romanian journal of internal medicine = Revue roumaine de medecine interne.
[15] S. Sakaguchi,et al. Molecular control of regulatory T cell development and function. , 2017, Current opinion in immunology.
[16] Ana C Anderson,et al. Lag-3, Tim-3, and TIGIT: Co-inhibitory Receptors with Specialized Functions in Immune Regulation. , 2016, Immunity.
[17] S. Zheng,et al. TGF-β–Induced Regulatory T Cells Directly Suppress B Cell Responses through a Noncytotoxic Mechanism , 2016, The Journal of Immunology.
[18] T. Braciale,et al. The host immune response in respiratory virus infection: balancing virus clearance and immunopathology , 2016, Seminars in Immunopathology.
[19] M. Mohammadnia-Afrouzi,et al. Decrease of CD4+ CD25+ CD127low FoxP3+ regulatory T cells with impaired suppressive function in untreated ulcerative colitis patients , 2015, Autoimmunity.
[20] P. Jorens,et al. The role of Th17 and Treg responses in the pathogenesis of RSV infection , 2015, Pediatric Research.
[21] J. Bluestone,et al. The therapeutic potential of regulatory T cells for the treatment of autoimmune disease , 2015, Expert opinion on therapeutic targets.
[22] L. King,et al. Regulatory T cell DNA methyltransferase inhibition accelerates resolution of lung inflammation. , 2015, American journal of respiratory cell and molecular biology.
[23] B. Li,et al. Critical role of all-trans retinoic acid in stabilizing human natural regulatory T cells under inflammatory conditions , 2014, Proceedings of the National Academy of Sciences.
[24] S. Zheng,et al. Regulatory T cells and B cells: implication on autoimmune diseases. , 2013, International journal of clinical and experimental pathology.
[25] Qizhi Tang,et al. Regulatory T-cell therapy in transplantation: moving to the clinic. , 2013, Cold Spring Harbor perspectives in medicine.
[26] R. Lechler,et al. Promoting transplantation tolerance; adoptive regulatory T cell therapy , 2013, Clinical and experimental immunology.
[27] D. Busch,et al. Foxp3+ regulatory T cells protect the liver from immune damage and compromise virus control during acute experimental hepatitis B virus infection in mice , 2012, Hepatology.
[28] S. Zheng,et al. Induced T regulatory cells suppress osteoclastogenesis and bone erosion in collagen-induced arthritis better than natural T regulatory cells , 2012, Annals of the rheumatic diseases.
[29] A. Rudensky,et al. Regulatory T cells: mechanisms of differentiation and function. , 2012, Annual review of immunology.
[30] K. Garcia,et al. The composition and signaling of the IL-35 receptor are unconventional , 2012, Nature Immunology.
[31] S. Zheng,et al. Induced Foxp3(+) regulatory T cells: a potential new weapon to treat autoimmune and inflammatory diseases? , 2012, Journal of molecular cell biology.
[32] M. Levings,et al. Moving to tolerance: clinical application of T regulatory cells. , 2011, Seminars in immunology.
[33] S. Zheng,et al. Characterization of Protective Human CD4+CD25+ FOXP3+ Regulatory T Cells Generated with IL-2, TGF-β and Retinoic Acid , 2010, PloS one.
[34] G. Kassiotis,et al. Suppression of Innate Immune Pathology by Regulatory T Cells during Influenza A Virus Infection of Immunodeficient Mice , 2010, Journal of Virology.
[35] S. Zheng,et al. Cutting Edge: All-Trans Retinoic Acid Sustains the Stability and Function of Natural Regulatory T Cells in an Inflammatory Milieu , 2010, The Journal of Immunology.
[36] S. Zheng,et al. Isolation of purified and live Foxp3+ regulatory T cells using FACS sorting on scatter plot. , 2010, Journal of molecular cell biology.
[37] L. King,et al. CD4+CD25+Foxp3+ Tregs resolve experimental lung injury in mice and are present in humans with acute lung injury. , 2009, The Journal of clinical investigation.
[38] A. Grakoui,et al. PD-1 tempers Tregs in chronic HCV infection. , 2009, The Journal of clinical investigation.
[39] S. Zheng,et al. Natural and TGF-beta-induced Foxp3(+)CD4(+) CD25(+) regulatory T cells are not mirror images of each other. , 2008, Trends in immunology.
[40] S. Zheng,et al. Cutting Edge: Foxp3+CD4+CD25+ Regulatory T Cells Induced by IL-2 and TGF-β Are Resistant to Th17 Conversion by IL-61 , 2008, The Journal of Immunology.
[41] C. June,et al. Adoptive T cell therapy for cancer in the clinic. , 2007, The Journal of clinical investigation.
[42] L. Boon,et al. Reverse signaling through GITR ligand enables dexamethasone to activate IDO in allergy , 2007, Nature Medicine.
[43] S. Zheng,et al. IL-2 Is Essential for TGF-β to Convert Naive CD4+CD25− Cells to CD25+Foxp3+ Regulatory T Cells and for Expansion of These Cells1 , 2007, The Journal of Immunology.
[44] T. Gingeras,et al. CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ T reg cells , 2006, The Journal of experimental medicine.
[45] S. Zheng,et al. TGF-β Requires CTLA-4 Early after T Cell Activation to Induce FoxP3 and Generate Adaptive CD4+CD25+ Regulatory Cells1 , 2006, The Journal of Immunology.
[46] S. Zheng,et al. Transfer of regulatory T cells generated ex vivo modifies graft rejection through induction of tolerogenic CD4+CD25+ cells in the recipient. , 2006, International immunology.
[47] R N Maini,et al. Evidence of radiographic benefit of treatment with infliximab plus methotrexate in rheumatoid arthritis patients who had no clinical improvement: a detailed subanalysis of data from the anti-tumor necrosis factor trial in rheumatoid arthritis with concomitant therapy study. , 2005, Arthritis and rheumatism.
[48] Michel Theron,et al. An interferon‐γ‐related cytokine storm in SARS patients† , 2004, Journal of medical virology.
[49] S. Zheng,et al. Natural and Induced CD4+CD25+ Cells Educate CD4+CD25− Cells to Develop Suppressive Activity: The Role of IL-2, TGF-β, and IL-101 , 2004, The Journal of Immunology.
[50] S. Zheng,et al. CD4+ and CD8+ Regulatory T Cells Generated Ex Vivo with IL-2 and TGF-β Suppress a Stimulatory Graft-versus-Host Disease with a Lupus-Like Syndrome1 , 2004, The Journal of Immunology.
[51] S. Zheng,et al. Generation Ex Vivo of TGF-β-Producing Regulatory T Cells from CD4+CD25− Precursors1 , 2002, The Journal of Immunology.
[52] A. Shapiro,et al. Combination therapy with sirolimus and interleukin-2 prevents spontaneous and recurrent autoimmune diabetes in NOD mice. , 2002, Diabetes.
[53] J. Shimizu,et al. Stimulation of CD25+CD4+ regulatory T cells through GITR breaks immunological self-tolerance , 2002, Nature Immunology.
[54] G. Pennesi,et al. Specific suppression of human CD4+ Th cell responses to pig MHC antigens by CD8+CD28- regulatory T cells. , 1998, Journal of immunology.